Crossmark

Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients

Crossref DOI link: https://doi.org/10.1186/s13014-021-01921-3

Published Online: 2021-10-02

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Ao

Wang, Yalin

Wang, Xin

Zhu, Liqiong

Nie, Yu

Li, Minghuan http://orcid.org/0000-0001-8662-1024
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82172677)

Qilu Hospital of Shandong University (2019QLQN09)
License Information

Text and Data Mining valid from 2021-10-02

Version of Record valid from 2021-10-02
More Information

Article History

Received: 26 August 2021

Accepted: 21 September 2021

First Online: 2 October 2021

Declarations

:

: The ethics committee of Shandong Cancer Hospital and Institute approved the study. The informed consent was exempted due to the retrospective nature of the study. All methods were carried out in accordance with relevant guidelines and regulations.

: All authors have approved the manuscript and agree with submission to Radiation Oncology.

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below